Biopharma Industry’s Latest Price Drops Save €15m on Government’s Medicines Bill, says IPHA

Ireland’s research-based pharmaceutical industry is set to save the Government €15 million on medicines by introducing price reductions today [Sunday] for more than 750 packs of innovative medicines

Read more

IPHA Urges Progress on Access to Medicines as Ireland Signs Up to BeNeLuxA

As Ireland signed up today [Friday] to the BeNeLuxA Initiative on pricing and supply of innovative medicines, the Irish Pharmaceutical Healthcare Association (IPHA) has said the focus of policymakers and industry must remain on fixing a slow and inefficient medicines approvals process for Irish patients

Read more

Focus must remain on biopharma innovation as European Commission proposes new IP laws, says IPHA

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry in Ireland, has said a continued focus on innovation is key to unlocking the potential of new medicines to improve healthcare outcomes and attract investments in the future.

Read more

Medicines Availability Bulletin Ireland and Europe

NEW IPHA RESEARCH SHOWS THAT IRELAND CONTINUES TO LAG EUROPE

  • Ireland lags western European countries in availability of new medicines
  • Nine medicines in the Irish reimbursement system are already available in 12 western European countries, on average.
  • Cancer and cardiovascular care the main therapy areas affected
  • Ireland 18th of 26 European countries in availability of new medicines:  latest EFPIA research

Read more

IPHA appoints Director of Communications and Advocacy

  • New role to help biopharma industry meet strategic engagement priorities
  • Move to work in partnership with Government and agencies on shared goals for faster access to new medicines in line with European peers
  • Industry keen to tell impactful story about healthcare and economic value

 

Read more

Oireachtas Health Committee report on Orphan Drugs welcomed by the pharmaceutical industry

The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47 research based pharmaceutical companies in Ireland has welcomed the publication of a report on Evaluating Orphan Drugs which has been published by the Joint Oireachtas Committee on Health.

Read more

IPHA welcomes updated IPPOSI position on access to innovative medicines

Revised ‘drug iceberg’ report a valuable contribution to ongoing debate on how best to ensure patients have timely access to the best medicines

Read more

Also in this section